Printable Medicines: A Microdosing Device For Producing Personalized Medicines - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Printable Medicines: A Microdosing Device For Producing Personalized Medicines
The authors describe a new method for the production of personalised medicines involving the direct printing of drug solutions or suspensions containing APIs and excipients onto edible paper carrier materials utilising ultra-precise microdrop printing technology. The approach allows ultra-precise dosing of the API according to the specific requirements of each individual patient and is suited for highly active low-dose drugs.


Pharmaceutical Technology Europe
Volume 23, Issue 1

Conclusions


The authors say...
We present a method for manufacturing a medication using microdrop printing technology, which offers new possibilities in the fields of personalised medicine, the production of lowdosage forms, including process verification, documentation and labelling, and the individual adjustment of the medication with respect to multidosing and controlled drug release. The system has already been extensively tested, provides an innovative mechanism to prevent counterfeit medications and seems to be suitable for the formulation of highly potent and active drug substances.

Christine Voura is Senior Researcher from the Research Center Pharmaceutical Engineering GmbH, Graz, Austria.

Michael M. Gruber is Junior Researcher from the Research Center Pharmaceutical Engineering GmbH, Graz, Austria.

Nina Schroedl is Technician from the Research Center Pharmaceutical Engineering GmbH, Graz, Austria.

Daniela Strohmeier is Technician from the Research Center Pharmaceutical Engineering GmbH, Graz, Austria.

Bernhard Eitzinger is R&D Manager from Dr. Franz Feurstein GmbH, Traun, Austria.

Wolfgang Bauer is Professor from the Institute for Paper, Pulp and Fibre Technology, Graz University of Technology, Graz, Austria.

Guenter Brenn is Professor from the Institute of Fluid Mechanics and Heat Transfer, Graz University of Technology, Graz, Austria.

Johannes G. Khinast is Professor from the Research Center Pharmaceutical Engineering GmbH, Graz/Austria and the Institute for Process and Particle Engineering, Graz University of Technology, Graz, Austria.

Andreas Zimmer is the article's corresponding author and Professor from the the Institute of Pharmaceutical Sciences, Karl-Franzens University of Graz, Graz, Austria.
Tel. +43 316 380 8880

References

1. W.E. Katstra et al., Journal of Controlled Release, 66(1), 1–9 (2000).

2. Patent Application WO 2010/012470 A1: A system and method for manufacturing a medication (2010).

3. W. Meyer, Farbe und Lack, 112(3), (2006).

4. E.R. Lee, Methods of Generating Monodisperse Microdrops. Microdrop Generation (CRC Press LCC, Florida, USA, 2003) pp 15–32.

5. BD. Glass and A. Haywood, J. Pharm. Pharmaceut. Sci., 9(3), 398–426 (2006).

6. T.J. Nicolson et al., Trends in Pharmacological Sciences, 31(3), 108–114 (2010).

7. FDA, Evaluation of Gender Differences in Clinical Investigations — Information Sheet. Clinical Trial Guidance (1998). http://www.fda.gov/

8. H. Ahmed and N. Shah, American Pharmaceutical Review, 3(3) (2000).

9. S. Yang and J.R.G. Evans, Powder Technology, 178(1), 56–72 (2007).

10. R. Mitchell and D. Edwards, Pharmaceutical Technology Europe, 21(7), 22–24 (2009).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology Europe,
Click here